These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4687877)

  • 1. Serum copper in Hodgkin's disease in children.
    Tessmer CF; Hrgovcic M; Wilbur J
    Cancer; 1973 Feb; 31(2):303-15. PubMed ID: 4687877
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of serum copper levels in adult patients with Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
    Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
    [No Abstract]   [Full Text] [Related]  

  • 3. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
    Wilimas J; Thompson E; Smith KL
    Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
    Thorling EB; Thorling K
    Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease.
    Jelliffe AM
    Natl Cancer Inst Monogr; 1973 May; 36():325-6. PubMed ID: 4744592
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
    Gupta SK; Shukla VK; Gupta V; Gupta S
    J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged observations on variations in the serum copper in Hodgkin's disease.
    Warren RL; Jelliffe AM; Watson JV; Hobbs CB
    Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Minckler TM; Mosier B; Taylor GH
    Cancer; 1968 Apr; 21(4):743-55. PubMed ID: 4868473
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
    Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
    Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
    [No Abstract]   [Full Text] [Related]  

  • 12. Interpreting serum copper levels in Hodgkin's disease.
    Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
    Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic value of copper, haptoglobin and alpha-2-globulin in the serum of patients with Hodgkin's disease].
    Cepelja Z; Grgić Z; Markinković M; Ivanov D
    Lijec Vjesn; 1975 May; 97(5):289-93. PubMed ID: 54857
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
    Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
    Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostics of relapse in hodgkin's disease (author's transl)].
    Dietzel F; Grebe SF; Ristig W; Schmidt HG; Steckenmesser R
    Med Klin; 1974 Feb; 69(7):289-92. PubMed ID: 4363084
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
    Kuleva SA
    Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and prognostic value of serum copper/zinc ratio in Hodgkin's disease.
    Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Suling H
    Biol Trace Elem Res; 2001 Nov; 83(2):133-8. PubMed ID: 11762530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 19. [When to terminate the treatment of children with Hodgkin's disease, lymphoblastic leukemia and non-Hodgkin's lymphoma. Analysis of 80 cases].
    Armata J
    Pediatr Pol; 1979 Aug; 54(8):877-85. PubMed ID: 291888
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of the blood copper in Hodgkin's disease.
    PAGLIARDI E; GIANGRANDI E
    Acta Haematol; 1960 Oct; 24():201-12. PubMed ID: 13732060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.